Heartwarming Study Reveals 94.5% of Kids Triumph Over Cancer Treatment: A Beacon of Hope in India
NEW DELHI: For countless families across India, the phrase “cancer-free” symbolizes both relief and a new chapter in life. However, the journey that follows treatment has remained largely uncharted territory until now. In a significant update ahead of International Childhood Cancer Day, researchers have unveiled India’s first comprehensive study on childhood cancer survivorship, tracking over 5,400 children who completed treatment at 20 centers nationwide, including major cities like Delhi, Mumbai, Chennai, Kolkata, and Bengaluru.
Initiated by the Indian Paediatric Haematology Oncology Group in 2016, this landmark Indian Childhood Cancer Survivorship study is published in The Lancet Regional Health – Southeast Asia. Lead author Dr. Rachna Seth, who heads the oncology division at AIIMS, New Delhi, explained that the project’s concept took shape in 2014 and became operational by 2016. The research covers data collected from 2016 to 2024.
“For years, the focus was solely on acute care-ensuring children survive,” said Dr. Seth. “Now that we know many do survive, it’s crucial to understand how they thrive after treatment.” The preliminary results are promising: the five-year overall survival rate stands at an impressive 94.5%, and the event-free survival rate reaches 89.9%. Remarkably, two years after treatment, this survival rate increases to 98.2%. As of December 2024, follow-up data reveal that 5,140 children are under observation, with 92% currently alive and in remission.
Leukemia accounted for 41% of the cases, marking it as the most prevalent diagnosis among the cohort. Other common cancers treated include Hodgkin lymphoma, bone tumors, and retinoblastoma. Almost all children underwent chemotherapy, while about 25% received radiotherapy, nearly one-third required surgical intervention, and more than half needed blood transfusions.
However, the journey towards survivorship doesn’t end with treatment. According to Dr. Seth, these young survivors face potential long-term medical and psychosocial challenges, including fertility issues, cardiac dysfunction, cognitive impairments, relapses, and an increased risk of secondary cancers. “These late effects need to be systematically documented,” she emphasized, noting that until now, much of the understanding in India relied on extrapolated data from Western studies.
While the published analysis captures insights from 20 centers, the initiative is expanding, with 35 to 36 centers currently contributing vital data. “This work establishes a baseline unique to our demographic,” Dr. Seth remarked. The average follow-up period for these children is roughly 3.9 years post-diagnosis, during which about 5.7% experienced a relapse, and 4.9% succumbed to the disease during follow-up.
This pivotal study not only bridges a significant gap in knowledge regarding childhood cancer survivorship in India but also highlights the importance of continued care and monitoring for thriving young patients. The findings underscore a growing recognition that survival is only the beginning; understanding the broader impact of cancer treatment on quality of life is crucial for the next phase of pediatric oncology care in India.
Original Source: https://timesofindia.indiatimes.com/india/94-5-kids-survive-after-cancer-treatment-study/articleshow/128361861.cms
Category :
Tags:
Publish Date: 2026-02-15 02:56:00
